The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial What we learn from subgroup analyses

被引：54
|
作者：
Ginsberg, Henry N. [1 ,2 ]
机构：
[1] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA
[2] Columbia Univ, Coll Phys & Surg, Irving Inst Clin & Translat Res, New York, NY USA
来源：
DIABETES CARE | 2011年 / 34卷
关键词：
CORONARY-HEART-DISEASE; LDL CHOLESTEROL; INTERVENTION; MEN; GEMFIBROZIL; PREVENTION; MORTALITY; THERAPY; PEOPLE;
D O I：
10.2337/dc11-s203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S107 / S108
页数：2
相关论文
共 50 条
  • [41] What can we learn from the genetics of diabetes?
    Bowden, DW
    GENETICS OF COMPLEX THYROID DISEASES, 2002, : 64 - 80
  • [42] What did we learn from the ARUBA trial?
    Russin, Jonathan
    Cohen-Gadol, Aaron A.
    NEUROSURGICAL FOCUS, 2014, 37 (03)
  • [43] Visual acuity outcomes after cataract surgery in type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study
    Lee, Debora
    Agron, Elvira
    Keenan, Tiarnan
    Lovato, James
    Ambrosius, Walter
    Chew, Emily Y.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (11) : 1496 - 1502
  • [44] Visual acuity outcomes of cataract surgery in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study
    Lee, Debora Hana
    Agron, Elvira
    Keenan, Tiarnan D. L.
    Greven, Craig M.
    Danis, Ronald P.
    Lovato, James F.
    Ambrosius, Walter T.
    Chew, Emily Y.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [45] What do we learn from repeated population analyses?
    Duffull, Stephen B.
    Wright, Daniel F. B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (01) : 40 - 47
  • [46] Persistent Effects of Intensive Glycemic Control on Retinopathy in Type 2 Diabetes in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Follow-On Study
    Chew, Emily Y.
    Lovato, James F.
    Davis, Matthew D.
    Gerstein, Hertzel C.
    Danis, Ronald P.
    Ismail-Beigi, Faramarz
    Genuth, Saul
    Greven, Craig M.
    Perdue, Letitia H.
    Cushman, William C.
    Elam, Marshall B.
    Bigger, J. Thomas
    Ginsberg, Henry N.
    Goff, David C., Jr.
    Ambrosius, Walter T.
    DIABETES CARE, 2016, 39 (07) : 1089 - 1100
  • [47] Systolic Blood Pressure Response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A Possible Explanation for Discordant Trial Results
    Huang, Chenxi
    Dhruva, Sanket S.
    Coppi, Andreas C.
    Warner, Frederick
    Li, Shu-Xia
    Lin, Haiqun
    Nasir, Khurram
    Krumholz, Harlan M.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (11):
  • [48] The Cross-sectional and Longitudinal Associations of Diabetic Retinopathy With Cognitive Function and Brain MRI Findings: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Hugenschmidt, Christina E.
    Lovato, James F.
    Ambrosius, Walter T.
    Bryan, R. Nick
    Gerstein, Hertzel C.
    Horowitz, Karen R.
    Launer, Lenore J.
    Lazar, Ronald M.
    Murray, Anne M.
    Chew, Emily Y.
    Danis, Ronald P.
    Williamson, Jeff D.
    Miller, Michael E.
    Ding, Jingzhong
    DIABETES CARE, 2014, 37 (12) : 3244 - 3252
  • [49] Cardiovascular Risk Prediction in Diabetes From Machine Learning: The ACCORD Study
    Fan, Wenjun
    Wong, David N.
    Li, Xiaowei
    Wong, Nathan
    CIRCULATION, 2020, 142
  • [50] The Genetics of Diabetes: What We Can Learn from Drosophila
    Liguori, Francesco
    Mascolo, Elisa
    Verni, Fiammetta
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (20)
12345